Drug intelligence / Profile preview

polidocanol + urea

Development stage
Unknown
Lead developer
Almirall
Modality
Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
Administration
Topical
01

Overview

Polidocanol + urea is a topical combination used primarily in dermatology for the symptomatic relief of pruritus (itching) and the treatment of dry skin conditions. Polidocanol acts as a local anesthetic and antipruritic agent, though its exact mechanism for itch relief is not fully defined; it may reduce nerve irritation and has mild anesthetic properties. Urea is a keratolytic and humectant that improves skin hydration by increasing water uptake in the stratum corneum, softening hyperkeratotic areas, and enhancing desquamation. The combination leverages both agents' effects to relieve itching while improving skin moisture barrier function. This combination is commonly found in over-the-counter creams such as Optiderm or Balneum Plus for eczema, xerosis (dry skin), atopic dermatitis, psoriasis, ichthyosis, and other pruritic dermatoses[3][4]. **Developers:** Almirall **Manufacturers:** Almirall

Brand names
OptidermBalneum Plus
Other names
polidocanol + ureapolidocanol/urealaureth-9 + urea

Beyond the preview

Go deeper on polidocanol + urea.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on polidocanol + urea.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call